Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1978 Oct 21;2(6145):1115–1117. doi: 10.1136/bmj.2.6145.1115

How often should patients be reviewed after treatment with iodine-131 for thyrotoxicosis?

A D Toft, W J Irvine, J Seth, E H Cameron
PMCID: PMC1608237  PMID: 709256

Abstract

Six to 18 years after treatment with iodine-131 for thyrotoxicosis 69 euthyroid patients with raised serum thyrotrophin (TSH) concentrations (mean 25.0 +/- SE 2.0 mU/l) and 61 with normal concentrations (mean 4.0 +/- 0.2 mU/l) were included in a prospective five-year follow-up study beginning in 1972. During this period 13 patients from the original group with raised serum TSH concentrations became hypothyroid. In contrast it was five years before hypothyroidism developed in a single patient from the group with normal serum TSH concentrations in 1972, although raised concentrations were recorded in 19 of these patients during the study.

Full text

PDF
1115

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bastenie P. A., Vanhaelst L., Golstein J., Smets P. Asymptomatic autoimmune thyroiditis and coronary heart-disease. Cross-sectional and prospective studies. Lancet. 1977 Jul 23;2(8030):155–158. doi: 10.1016/s0140-6736(77)90177-5. [DOI] [PubMed] [Google Scholar]
  2. Fowler P. B. Premyxoedema--a cause of preventable coronary heart disease. Proc R Soc Med. 1977 May;70(5):297–299. doi: 10.1177/003591577707000501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Irvine W. J., Toft A. D., Hunter W. M., Kirkham K. E. An assessment of plasma TSH radioimmunoassay and of the TSH stimulation test in the diagnosis of 100 consecutive patients with suspected hypothyroidism. Clin Endocrinol (Oxf) 1973 Apr;2(2):135–139. doi: 10.1111/j.1365-2265.1973.tb00413.x. [DOI] [PubMed] [Google Scholar]
  4. Mukhtar E. D., Smith B. R., Pyle G. A., Hall R., Vice P. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet. 1975 Mar 29;1(7909):713–715. doi: 10.1016/s0140-6736(75)91629-3. [DOI] [PubMed] [Google Scholar]
  5. Seth J., Toft A. D., Irvine W. J. Simple solid-phase radioimmunoassays for total tri-iodothyronine and thyroxine in serum, and their clinical evaluation. Clin Chim Acta. 1976 May 3;68(3):291–301. doi: 10.1016/0009-8981(76)90394-6. [DOI] [PubMed] [Google Scholar]
  6. Toft A. D., Irvine W. J., Seth J., Hunter W. M., Cameron E. H. Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosis. Lancet. 1975 Sep 27;2(7935):576–578. doi: 10.1016/s0140-6736(75)90169-5. [DOI] [PubMed] [Google Scholar]
  7. Wise P. H., Burnet R. B., Ahmad A., Harding P. E. Intentional radioiodine ablation in Graves' disease. Lancet. 1975 Dec 20;2(7947):1231–1233. doi: 10.1016/s0140-6736(75)92071-1. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES